Authors: HALLENBECK PL CHANG YN STEWART D HAY C GOLIGHTLY D CHIANG YL

Citation: Pl. Hallenbeck et al., NOVEL TUMOR-SPECIFIC REPLICATION RESTRICTED ADENOVIRAL VECTOR FOR GENE-THERAPY OF LIVER-CANCER, Cancer gene therapy, 4(6), 1997, pp. 38-38

Authors: CHOU CS GOLIGHTLY D PHIPPS S CHEN CY CHIANG Y CHANG YN

Citation: Cs. Chou et al., DEVELOPMENT OF A NOVEL HELPER-FREE SV40 GUTLESS VECTOR SYSTEM, Cancer gene therapy, 4(6), 1997, pp. 49-49

Authors: LOVELAND KG SOUTHWICK PC DAGOSTINO D RATLIFF TL BECK J LAMB DJ LOTT N DAUM P WENER MH KELLEY CA CHAN DW KASKE D GOLIGHTLY D LAYCO G OTA M MCBRIDE JH GRUDZIEN C TANASIJEVIC MJ GASIOR GH

Citation: Kg. Loveland et al., ANALYSIS OF HYBRITECH TANDEM(R) FREE PSA IN THE DIFFERENTIATION OF PROSTATE-CANCER FROM BENIGN PROSTATIC DISEASE - RESULTS OF A MULTICENTERCLINICAL-TRIAL, Clinical chemistry, 43, 1997, pp. 553-553

Authors: HALLENBECK PL CHANG YN HAY C GOLIGHTLY D STEWART D MCGARRITY G CHIANG Y

Citation: Pl. Hallenbeck et al., NOVEL TUMOR-SPECIFIC REPLICATION COMPETENT ADENOVIRAL VECTORS FOR GENE-THERAPY OF CANCER, Cancer gene therapy, 3(6), 1996, pp. 36-36

Authors: LOVELAND K SOUTHWICK P RATLIFF T RITCHEY J DAGOSTINO D TANASIJEVIC M GRUDZIEN C ROGUS B GOLIGHTLY D CHAN D KELLEY C LAMB D BECK J WENER M DAUM P

Citation: K. Loveland et al., HYBRITECH TANDEM(R)-R FREE PSA ASSAY PERFORMANCE, Clinical chemistry, 42(6), 1996, pp. 665-665